Notably, TyG-BMI demonstrated superior performance compared to traditional indicators like TG, BMI, insulin, FPG, and HOMA-IR in the prediction of GDM, suggesting its potential utility as an early screening instrument in clinical environments for identifying women at increased risk for GDM. The gene discussed is INS; the disease is gestational diabetes.